Calcium channel blocker and renal mitochondrial function in warm renal ischemia. 2005

Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
Laboratory of Experimental Surgery, Department of Surgery and Anatomy, Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirao Preto, SP, Brazil. stucci@convex.com.br

OBJECTIVE Ions, particularly calcium ions, play an important role in ischemia-reperfusion cell injury. In this study, we investigated the action of verapamil on the mitochondrial function of kidneys submitted to ischemia without blood reperfusion in order to study isolated early and late ischemic effects. METHODS 44 rats were submitted to bilateral warm renal ischemia for 30 minutes. The kidneys were then immediately reperfused with saline or Euro-Collins (EC) solution, with and without previous administration of 0.35 mg/kg of verapamil. Mitochondrial function was assessed at the end of renal perfusion and after 24 hours of cold preservation. RESULTS In kidneys perfused with saline, verapamil allowed a significant early preservation of state III mitochondrial respiration, a result that was no longer evident after 24 hours. In kidneys perfused with EC solution, verapamil did not change state III for either early or late evaluations. Comparison of the groups showed that the results obtained for kidneys perfused with EC were always superior to those obtained for the saline group, except for the initial analysis of kidneys treated with saline and verapamil, which showed results similar to those obtained with EC perfusion alone. CONCLUSIONS Administration of verapamil before warm ischemia provides partial and short-lasting functional protection of the mitochondrial function in kidneys perfused with sodium rich saline. With Euro-Collins solution, verapamil did not show any additional beneficial effect. This fact permits us to conclude that protective action is effective only under conditions that facilitate increased sodium uptake and/or potassium loss.

UI MeSH Term Description Entries
D006982 Hypertonic Solutions Solutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid. Hypertonic Solution,Solution, Hypertonic,Solutions, Hypertonic
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D050377 Cold Ischemia The chilling of a tissue or organ during decreased BLOOD perfusion or in the absence of blood supply. Cold ischemia time during ORGAN TRANSPLANTATION begins when the organ is cooled with a cold perfusion solution after ORGAN PROCUREMENT surgery, and ends after the tissue reaches physiological temperature during implantation procedures. Cold Ischemia Time,Cold Ischemic Time,Cold Ischemia Times,Ischemia, Cold,Time, Cold Ischemia

Related Publications

Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
August 1996, The Journal of surgical research,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
October 1993, The Journal of surgical research,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
January 2014, Annals of emergency medicine,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
January 2008, Acta cirurgica brasileira,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
January 1990, Renal failure,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
March 1994, Scandinavian journal of urology and nephrology,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
October 2006, Nihon rinsho. Japanese journal of clinical medicine,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
February 2010, Clinical therapeutics,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
October 1998, Nihon rinsho. Japanese journal of clinical medicine,
Silvio Tucci, and Tiago J Borelli-Bovo, and Adauto J Cologna, and Ricardo B Tiraboschi, and Antonio C P Martins, and Jose E S Roselino
June 2016, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!